Key findings

Tamoxifen is safe and well-tolerated when used as an adjunct to corticosteroids in boys with Duchenne muscular dystrophy, but it does not slow progression of the disease, finds a European randomised controlled trial reported in the journal Lancet Neurology .

Background

Tamoxifen showed promise in preclinical research and ...